Brief: Calliditas Receives Notice Of Allowance In U.S For Tarpeyo
Dec 11 (Reuters) - Calliditas Therapeutics AB
CALTX.ST :
* CALLIDITAS RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES
PATENT
APPLICATION COVERING TARPEYO®
* EXPECTS RESULTING PATENT WILL BE ORANGE BOOK-LISTABLE,
WITH
ANTICIPATED EXPIRATION DATE IN 2043
Source text for Eikon: ID:nWkr7YXbv8
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations